Skip to main content
. 2012 Mar 13;2012:614212. doi: 10.1155/2012/614212

Table 2.

Characteristics of the PD cases and controls included in analysis.

Site Type Gender Age, years (range) PMI, hours (range) Tissue pH (range) PD Duration, years (range)
HBSFRC 2 C 2M 86.5 (80–93) 19.5 (13–26) 6.41 (6.26–6.55) N/A
17 PD 9F/8M 82.2 (63–95) 16.3 (9–37) 6.30 (6.02–6.62) 11.5 (4–28)
BTRC 39 C 39M 61.4 (36–106) 21.9 (10–39.6) 6.71 (5.95–7.32) N/A
35 PD 35M 76.3 (64–95) 17.9 (6.6–30.7) 6.50 (5.86–7.13) 11.2 (3–23)
SHRI 23 C 13F/10M 84.3 (63–97) 2.68 (1–5.5) 6.71 (6.29–7.13) N/A
49 PD 11F/38M 78.5 (64–90) 3.11 (1–10) 6.59 (6.17–7.44) 10.4 (0–40)
All 64 C 13F/51M 70.5 (36–106) 14.9 (1–39.6) 6.70 (5.95–7.32) N/A
101 PD 20F/81M 78.3 (63–95) 10.4 (1–37) 6.51 (5.86–7.44) 10.9 (0–40)
Final C Set* 46 C 13F/33M 77.2 (58–97) 11.7 (1–39.6) 6.67 (5.95–7.32) N/A

C: Control; PD: Parkinson disease.

HBSFRC = Human Brain and Spinal Fluid Resource Center VA West Los Angeles Healthcare Center.

HBTRC = Harvard Brain Tissue Resource Center, McLean Hospital, Belmont, Massachusetts.

SHRI = Sun Health Research Institute in Sun City, Arizona.

*after removing controls with age at death ± 5 years beyond age at death of cases (< age 58 or > age 100).